📈 Big Tech earnings

Good morning.

The Fast Five → Market’s fate rests on Big Tech earnings, HK court orders China Evergrande to liquidate, Fed rate decision could signal March cut, United Airlines resumes Boeing 737 MAX 9 flights, and world's largest cruise ship sets sail from Miami…

Calendar:

• Wednesday, 1/31: Fed interest-rate decision, 2:00p ET

• Friday, 2/2: US unemployment rate, 8:30a ET

Your 5-minute briefing for Monday, January 29:

Elevate Your Trading Insights! Subscribe to Our Partner's Newsletter for Timely Stock Trading News, Expert Analyses, and Market Trends. Don't Miss Out on Valuable Information – Stay Informed, Trade Smart!

Please support my sponsors *Enable Select All and Click Continue* 

It’s how I pay the bills to keep this newsletter free :)

Please check your email to confirm the subscription. Thank you

BEFORE THE OPEN

PRE-MARKET

MARKETS

• US stocks closed mixed but clinched weekly gains thanks to the latest positive economic data

• The Nasdaq fell 0.36%, while the Dow rose 0.16%

• European stocks rose to close at a two-year high as investors digested the ECB’s latest rate decision, Q4 earnings, and fresh economic data

EARNINGS

• American Express shares jumped 7% after a better-than-expected 2024 earnings forecast; however, Q4 results fell short of expectations (link)

• What we're watching this week:

• Today: Cleveland-Cliffs

• Tuesday: Microsoft, Alphabet, AMD, Starbucks, GM, UPS, JetBlue

• Wednesday: Qualcomm, Boeing, Novo Nordisk

• Thursday: Apple, Amazon, Meta, Royal Caribbean, Altria

• Friday: Exxon, Chevron, Bristol Myers Squibb, AbbVie, Cigna

• Full calendar here

NEWS BRIEFING

This Week: Stock Market’s Fate Rests on $10 Trillion in Big Tech Earnings

Evergrande Shares Halted After Hong Kong Court Orders Liquidation

• Fed rate decision could be the prelude to a March cut (link)

• Plummeting inflation raises new risk for Fed: rising real interest rates (link)

• Goldman, JPMorgan see euro challenging yen as carry-trade funder (link)

• Meta welcomes headset war with Apple (link)

• Traders line up for a ‘once-in-a-generation’ emerging markets bet (link)

• Argentina’s President promised a free-market revolution, and says he’s delivering (link)

• China tightens securities lending rule to support stock market (link)

• United Airlines resumes Boeing 737 MAX 9 flights after inspections (link)

• Aviation’s wheelers and dealers meet under shadow of MAX crisis (link)

• United CEO kickstarts Airbus talks amid Boeing delays (link)

• Bank of America employees to share $800M stock reward (link)

• Big pharma is at a crossroads, as J&J, Merck and others prepare to lose heaps of revenue from blockbuster drugs (link)

• Unhappy workers cost US firms $1.9T (link)

• Taylor Swift’s name not searchable on X days after sexually explicit deepfakes go viral (link)

• Musk’s X pledges 100-person office in Texas to police content (link)

• Three US troops killed in drone attack in Jordan (link)

• World's largest cruise ship sets sail from Miami (link)

CRYPTO

• FTX and its affiliates are unloading crypto assets to pay back customers, nearly doubling its cash hoard to $4.4B by the end of 2023 (link)

• BlackRock’s Bitcoin ETF reached $2B AUM (link)

You Can Sponsor this Newsletter details here.​

BULLISH BITES

🤝 Powershift: The introverts have taken over the US economy.

👀 Watching: Federal judges will soon decide whether crypto can be regulated like stocks and bonds.

🙌 Game-changer: Google’s Lumiere brings AI video closer to real than unreal.

🔎 In the spotlight: Unhappy workers cost US firms $1.9 Trillion.

FEATURED TRADES

RBC upgrades $EVO to Outperform

Evotec SE (ticker: EVO) is a drug discovery alliance and development partnership company that provides drug discovery solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and venture capitalists. It offers various drug discovery services, including target identification and validation, screening, medicinal chemistry, and drug optimization.

Ticker: EVO | Price: $7.89 | Price Target: $18.60 (+136%)

Market Cap: $3B | Timeframe: N/A

🧪 Biotech / Pharma | 🔄 Turnaround | 📈 Bullish Idea

Read the full article here. Read time: 2 min

DAILY SHARES

Keep the curation going! Buy the team a coffee ☕️